Received Oct 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
vaccine was administered little above the elbow instead of the deltoid muscle; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of vaccine administered at inappropriate site in a female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix (unknown arm). On an unknown date, an unknown time after receiving Shingrix, the patient experienced vaccine administered at inappropriate site (Verbatim: vaccine was administered little above the elbow instead of the deltoid muscle). The outcome of the vaccine administered at inappropriate site was not applicable. Additional Information: GSK Receipt Date: 19-SEP-2025 A pharmacist reported that a patient had received the first dose of Shingrix a couple of days ago and the vaccine was administered little above the elbow instead of the deltoid muscle. The patient was concerned about the validity of the dose. They were not sure if the vaccine was given IM or SC. The reporter did not provide the precise date of administration and mentioned that patient is in her low 60´s (not precise age was mentioned).